Advancing the Care of Post-Acne Scarring: Expert Insights into New Treatment Options

Advancing the Care of Post-Acne Scarring: Expert Insights into New Treatment Options

Release Date: May 11, 2016
Last Reviewed: April 21, 2016

Expiration Date: May 11, 2017

Time to Complete Activity:  1.5 hours
 

*This activity expired for credit on May 11, 2017 and is no longer available for credit
 

Associate Clinical Professor of Medicine/Dermatology

University of Washington School of Medicine

Seattle, WA

This activity is provided by Paradigm Medical Communications, LLC.  

Target Audience

This activity has been designed to meet the educational needs of dermatologists, nurse practitioners, physician assistants, and other healthcare providers who are involved in the treatment of atrophic facial scars of acne vulgaris.

 

Upon proper completion of this activity, participants should be better able to:

 

Paradigm Medical Communications, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

 

Paradigm Medical Communications, LLC designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. Physician assistants may receive a maximum of 1.5 hours of Category 1 credit for completing this program.
 

Nurse Practitioner Continuing Education
The American Academy of Nurse Practitioners Certification Program (AANPCP) accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME.  Individuals are responsible for checking with the AANPCP for further guidelines.
 

This activity is supported by an educational grant from Suneva Medical, Inc.

 

To receive a CME certificate of participation, you should:

 

A certificate of participation will be available for download/printing immediately following your successful completion of the posttest and evaluation.

For questions regarding CME credit, contact the Paradigm CME Department at (845) 398-5949.

 

There is no fee required for participation in this activity.

This certified CME activity is designed using HTML5 video. As you navigate the video using the supplied controls, the slides will sync to the speaker.

 

For Desktops (Windows/Mac)

Internet Explorer 9 or higher, Firefox 28 or higher, Safari 5.1 or higher, Google Chrome 31 or higher, Opera 21 or higher

 

For Tablets (iPad/Android/Surface)

iOS Safari 4 or higher, Android 2.3 or higher, IE Mobile 10 or higher
 

Technical Support: If you have any technical problems or playback issues email us at contactus@paradigmmc.com.

 

In accordance with Accreditation Council for Continuing Medical Education requirements on disclosure, faculty and contributors are asked to disclose any relationships with commercial interests associated with the area of medicine featured in the activity. These relationships are described below.

 

Director, The Few Institute for Aesthetic Plastic Surgery

Clinical Professor, The University of Chicago

Clinician, Northwestern University

Chicago, IL

Consultant and Contracted Research: Allergan, Inc; Galderma Laboratories; Kythera Biopharmaceuticals, Inc; Merz Aesthetics, Inc; Neothetics, Inc; Suneva Medical, Inc; Ulthera, Inc; Venus Concept; ZELTIQ Aesthetics, Inc

 

Assistant Clinical Professor

Department of Head and Neck Surgery

University of California Los Angeles

Los Angeles, CA

Director, Clinical Testing of Beverly Hills

John J. Joseph, MD

Beverly Hills, CA

Advisory Board: Galderma Laboratories; Merz Aesthetics, Inc; Suneva Medical, Inc

Contracted Research: Alphaeon Corporation; Biologica Technologies, LLC; Chroma Technology Corporation; Galderma Laboratories; Kythera Biopharmaceuticals, Inc; Neothetics, Inc; RXi Pharmaceuticals Corporation; Teoxane/Alphaeon Corporation; Ulthera, Inc

Speaker: Galderma Laboratories; Kythera Biopharmaceuticals, Inc; Suneva Medical, Inc

Stockholder: Alphaeon Corporation; Revance Therapeutics, Inc; Skin Vent; Suneva Medical, Inc

Professor of Clinical Dermatology

Mount Sinai School of Medicine

New York, NY

Spencer Dermatology and Skin Surgery Center

St. Petersburg, FL

Speaker: Suneva Medical, Inc.

Amy Forman Taub, MD
Founder and Medical Director
Advanced Dermatology & Skinfo Specialty Skincare Boutique
Lincolnshire and Glencoe, IL
Assistant Clinical Professor
Northwestern University Feinberg School of Medicine
Chicago, IL

Consultant: DUSA Pharmaceuticals, Inc; Skinmedica; Suneva Medical, Inc

Contracted Research: DUSA Pharmaceuticals, Inc; MediCell Technologies

Ownership Interest: MediCell Technologies; Sterilis Medical Corporation

Reduced Equipment: EndyMed Medical Ltd
Speaker: Acclaris, Allergan, Inc; DUSA Pharmaceuticals, Inc; Kythera Biopharmaceuticals, Inc; Suneva Medical, Inc; Syneron Candela; PCA Skin

 

Associate Clinical Professor of Medicine/Dermatology

University of Washington School of Medicine

Seattle, WA

Consultant: AbbVie, Inc; Suneva Medical, Inc; Ulthera, Inc

Contracted Research: Allergan, Inc; Amgen Inc; DermAvance Pharmaceuticals Inc; Galderma Laboratories; Genentech, Inc; Kythera Biopharmaceuticals, Inc; Suneva Medical, Inc; Ulthera, Inc

Speaker: AbbVie, Inc; Allergan, Inc; Celgene Corporation; LEO Pharma, Inc; Merz Aesthetics, Inc; Ulthera, Inc; Xoft, Inc

 

Paradigm Medical Communications, LLC staff members have no financial relationships to disclose.

 

Peer reviewer, Giuseppe Militello, MD has the following financial relationships to disclose:

Advisory Board: Valeant Pharmaceuticals International, Inc
Speaker’s Bureau: Valeant Pharmaceuticals International, Inc

 

Resolution of Conflict of Interest
Paradigm Medical Communications, LLC has implemented a system to resolve conflicts of interest for each CME activity to help ensure content objectivity, independence, fair balance, and that the content is aligned with the interest of the public. Conflicts, if any, are resolved through one or more processes. All CME content in this activity was independently reviewed to ensure that it is free of commercial bias, scientifically rigorous, aligned with the public interest, and compliant with all regulatory guidance and the ACCME’s Standards for Commercial Support of Continuing Medical Education.
 

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA.

 

This CME activity represents the views and opinions of the individual faculty, and does not constitute the opinion or endorsement of, or promotion by, Paradigm Medical Communications, LLC. Reasonable efforts have been taken to present educational subject matter in a balanced, unbiased fashion, and in compliance with regulatory requirements. However, each activity participant must always use his or her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.

If included, signed statements of informed consent granting permission for publication have been obtained for all photographs and videos in which an individual can be identified.

 

As an ACCME-accredited provider, Paradigm Medical Communications, LLC activities must include a balanced view of therapeutic options. Use of generic names contributes to this impartiality. The use of trade names should not be viewed as an endorsement of specific products by Paradigm Medical Communications, LLC.

 

The materials provided for this activity are for informational purposes only, and should not be used for diagnosis or treatment of a health problem without consulting a licensed medical professional. Any views or opinions presented are solely those of the Faculty, and do not necessarily represent those of Paradigm Medical Communications, LLC. References to any entity, product, service, or source of information on this website should not be considered an endorsement, either direct or implied, by Paradigm Medical Communications, LLC. Paradigm Medical Communications, LLC accepts no liability for the content referenced in this activity.

 

Paradigm Medical Communications, LLC is committed to protecting the privacy of those who participate in the activities (herein referred to as "website") located at www.paradigmmc.com. The information below describes the security of the website for safeguarding personal information and the rationale for collection and use of personal information.

 

This website has physical and procedural safeguards in place to prevent unauthorized access to personal information used to access this website.

 

The submission of certain personally identifiable information is necessary to award and track the credits participants may earn after completing the program. Required items include first name, last name, degree, and email address. These items are necessary. Participants are also required to complete an evaluation of the CME activity. All evaluative information submitted is collected and retained, and used by Paradigm Medical Communications, LLC to continuously improve the learning experience.

 

Paradigm Medical Communications, LLC does not transfer, sell, or share personal information with outside parties. Paradigm Medical Communications, LLC will not otherwise disclose personal information unless required to in a legal process. Paradigm Medical Communications, LLC staff members review individual test results to the extent necessary to record and track participants’ credits.

 

Contact Us
If you have any questions or comments, please email us at contactus@paradigmmc.com.

 

© 2016 Paradigm Medical Communications, LLC, except where noted. Content may not be reproduced in whole or part without the express written permission of Paradigm Medical Communications, LLC.